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ABSTRACT
Aim:
The aim of this study is to quantitatively evaluate and compare bone regeneration in 
periapical lesions using a combination of Platelet Rich Plasma + β-Tricalcium phosphate and 
Platelet Rich Fibrin + β –Tricalcium phosphate.
Materials And Methods: 
Ten subjects with periapical lesion measuring 10-20 mm in relation to maxillary anteriors 
indicated   for  periapical surgery were selected . Pre operative bone density values at periapical 
region were measured in Hounsefield units using CBCT. Root canal treatment was completed 
appropriately in all the cases. Under adequate local anesthesia full thickness mucoperiosteal flap 
was raised, debridement of the periapical lesion followed by root end resection and retrograde 
filling was done. The 10 subjects were randomly divided into two groups. In Group I, periapical 
bone defect was filled with PRP + β-TCP and in Group II, with PRF + β-TCP. The 
mucoperiosteal flaps were repositioned and sutured. Bone density evaluation of the periapical
region was done 6 months and 1 year after surgery using CBCT and the HU values were 
obtained.
Results:
Mean 6 months HU value obtained for group I and group II were significantly higher 
than the respective pre op values of both groups.Mean 1 Year HU value obtained for group I and 
group II were higher than the respective pre op and 6 months HU     values. There was no 
statistically significant difference in bone density HU values between the two groups at 6 
Months and 1 year post operatively. 
Conclusion:
Both the combinations PRP + β-TCP and PRF + β-TCP are equally effective in 
promoting bone regeneration and can be considered to be valuable options for placement in 
periapical bone defects.
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